Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells
- PMID: 19671686
- DOI: 10.1158/1541-7786.MCR-08-0558
Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells
Abstract
Smad2 and Smad3 are intracellular mediators of transforming growth factor beta (TGFbeta) signaling that share various biochemical properties, but data emerging from functional analyses in several cell types indicate that these two Smad proteins may convey distinct cellular responses. Therefore, we have investigated the individual roles of Smad2 and Smad3 in mediating the cytostatic and proapoptotic effects of TGFbeta as well as their function in epithelial-to-mesenchymal transition. For this purpose, we transiently depleted mouse mammary epithelial cells (Nme) of Smad2 and/or Smad3 mainly by a strategy relying on RNaseH-induced degradation of mRNA. The effect of such depletion on hallmark events of TGFbeta-driven epithelial-to-mesenchymal transition was analyzed, including dissolution of epithelial junctions, formation of stress fibers and focal adhesions, activation of metalloproteinases, and transcriptional regulation of acknowledged target genes. Furthermore, we investigated the effect of Smad2 and Smad3 knockdown on the TGFbeta-regulated transcriptome by microarray analysis. Our results identify Smad3 as a key factor to trigger TGFbeta-regulated events and ascribe tumor suppressor as well as oncogenic activities to this protein.
Similar articles
-
A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.J Cell Biochem. 2007 May 1;101(1):9-33. doi: 10.1002/jcb.21255. J Cell Biochem. 2007. PMID: 17340614 Review.
-
Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta.Cell Growth Differ. 2002 Mar;13(3):123-30. Cell Growth Differ. 2002. PMID: 11959813
-
Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture.Dev Biol. 1998 Feb 15;194(2):182-95. doi: 10.1006/dbio.1997.8825. Dev Biol. 1998. PMID: 9501027
-
Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor beta signaling.Mol Cell Biol. 2009 Jan;29(1):172-86. doi: 10.1128/MCB.01038-08. Epub 2008 Oct 27. Mol Cell Biol. 2009. PMID: 18955504 Free PMC article.
-
Smaddening complexity: the role of Smad3 in epithelial-myofibroblast transition.Cells Tissues Organs. 2011;193(1-2):41-52. doi: 10.1159/000320180. Epub 2010 Nov 3. Cells Tissues Organs. 2011. PMID: 21051861 Review.
Cited by
-
Four amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteins.PLoS One. 2013 Oct 11;8(10):e76733. doi: 10.1371/journal.pone.0076733. eCollection 2013. PLoS One. 2013. PMID: 24146916 Free PMC article.
-
RETRACTED: Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.Molecules. 2019 Mar 21;24(6):1131. doi: 10.3390/molecules24061131. Molecules. 2019. Retraction in: Molecules. 2025 Jun 06;30(12):2481. doi: 10.3390/molecules30122481. PMID: 30901941 Free PMC article. Retracted.
-
Targeted dephosphorylation of SMAD3 as an approach to impede TGF-β signaling.iScience. 2024 Jul 5;27(8):110423. doi: 10.1016/j.isci.2024.110423. eCollection 2024 Aug 16. iScience. 2024. PMID: 39104417 Free PMC article.
-
The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.PLoS One. 2015 Sep 25;10(9):e0139179. doi: 10.1371/journal.pone.0139179. eCollection 2015. PLoS One. 2015. PMID: 26407179 Free PMC article.
-
Involvement of Ras GTPase-activating protein SH3 domain-binding protein 1 in the epithelial-to-mesenchymal transition-induced metastasis of breast cancer cells via the Smad signaling pathway.Oncotarget. 2015 Jul 10;6(19):17039-53. doi: 10.18632/oncotarget.3636. Oncotarget. 2015. PMID: 25962958 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources